Related Experiment Video
Updated: Mar 14, 2026

A Two-Step Strategy that Combines Epigenetic Modification and Biomechanical Cues to Generate Mammalian Pluripotent Cells
Published on: August 29, 2020
PRL-3 disrupts epithelial architecture by altering the post-mitotic midbody position
Pablo Luján1, Giulia Varsano1, Teresa Rubio1
1European Molecular Biology Laboratory, Genome Biology Unit, Heidelberg 69117, Germany.
Abstract:
Disruption of epithelial architecture is a fundamental event during epithelial tumorigenesis. We show that the expression of the cancer-promoting phosphatase PRL-3 (PTP4A3), which is overexpressed in several epithelial cancers, in polarized epithelial MDCK and Caco2 cells leads to invasion and the formation of multiple ectopic, fully polarized lumens in cysts. Both processes disrupt epithelial architecture and are hallmarks of cancer. The pathological relevance of these findings is supported by the knockdown of endogenous PRL-3 in MCF-7 breast cancer cells grown in three-dimensional branched structures, showing the rescue from multiple-lumen- to single-lumen-containing branch ends. Mechanistically, it has been previously shown that ectopic lumens can arise from midbodies that have been mislocalized through the loss of mitotic spindle orientation or through the loss of asymmetric abscission. Here, we show that PRL-3 triggers ectopic lumen formation through midbody mispositioning without altering the spindle orientation or asymmetric abscission, instead, PRL-3 accelerates cytokinesis, suggesting that this process is an alternative new mechanism for ectopic lumen formation in MDCK cysts. The disruption of epithelial architecture by PRL-3 revealed here is a newly recognized mechanism for PRL-3-promoted cancer progression.
Insights
The phosphatase PRL-3 (PTP4A3) promotes cancer by disrupting epithelial architecture. It causes cells to form multiple lumens, a key cancer hallmark, by accelerating cell division.
Area of Science:
- Cell Biology
- Cancer Research
- Epithelial Biology
Background:
- Epithelial architecture disruption is crucial in cancer development.
- PRL-3 (PTP4A3) is a phosphatase overexpressed in various epithelial cancers.
- Ectopic lumen formation is a hallmark of cancer progression.
Purpose of the Study:
- To investigate the role of PRL-3 (PTP4A3) in disrupting epithelial architecture.
- To elucidate the mechanism by which PRL-3 promotes ectopic lumen formation.
- To validate the role of PRL-3 in breast cancer cell models.
Main Methods:
- Expression of PRL-3 in polarized epithelial cells (MDCK, Caco2) and analysis of cyst formation.
- Knockdown of endogenous PRL-3 in MCF-7 breast cancer cells cultured in 3D structures.
- Microscopic analysis of cell division, spindle orientation, and midbody localization.
Main Results:
- PRL-3 expression induced cell invasion and formation of multiple ectopic lumens in epithelial cysts.
- Knockdown of PRL-3 reversed multiple-lumen formation to single-lumen structures in breast cancer cells.
- PRL-3 accelerated cytokinesis, leading to midbody mispositioning and ectopic lumen formation without affecting spindle orientation or abscission.
Conclusions:
- PRL-3 (PTP4A3) disrupts epithelial architecture, promoting cancer progression through a novel mechanism.
- PRL-3-induced ectopic lumen formation occurs via accelerated cytokinesis and midbody mispositioning.
- Targeting PRL-3 may offer a therapeutic strategy for epithelial cancers.
Related Concept Videos
Cell Motility through Blebbing
Blebbing Through the Matrix
In multicellular...
The Phragmoplast
The...
Disassembly of Intermediate Filaments
Keratin proteins, found at the cell periphery near cell junctions, undergo a cycle of assembly and disassembly. In Type...
Abnormal Proliferation

